CORRECTION OF ANEMIA BY TRANSFUSIONS OF DONOR ERYTHROCYTES IN PATIENTS WITH APLASTIC ANEMIA RECEIVING IMMUNOSUPPRESSIVE THERAPY

Abstract

Aplastic anemia (AA) is a disease associated with the failure of the hematopoietic bone marrow, accompanied by pancytopenia of varying severity. Anemic syndrome is a natural manifestation of the disease. One of the main criteria for achieving partial remission (CR) in AA patients is independence from blood components in previously transfusion-dependent patients. Transfusion support is required in the initial stages of the disease for most patients, but its frequency and volume can vary significantly and do not always depend on the severity of the disease.